Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Koen Vercauteren

Awards & Distinctions

30 Results

2021

Are VIDAS® anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections? Comparison & case story telling

Lien CattoirKoen VercauterenElizaveta PadalkoHans De BeenhouwerKristien Van VaerenberghAn Boel

A1 Journal Article in ACTA CLINICA BELGICA

2020

Do expected and real cadaver releases/rejections correspond? Towards simplified decision trees for the interpretation of serological tests in the body donation program

Brecht ValckeKatharina D'HerdeElizaveta PadalkoKoen VercauterenWouter Willaert

Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes

Eleftherios MichailidisKoen VercauterenLiliana Mancio-SilvaLinda AndrusCyprien JahanInna Ricardo-LaxChenhui ZouMohammad KabbaniPaul ParkCorrine Quirk et al.

A1 Journal Article in PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Infectious serology and demographics in the body donation program in 2011-2018 at Ghent University

Brecht ValckeKatharina D'HerdeElizaveta PadalkoKoen VercauterenWouter Willaert

Prospective multicenter comparison of urine culture with PCR on dried blood spots using 2 different extraction and PCR methods in neonates suspected for congenital cytomegalovirus infection

Koen VercauterenAnnelies KeymeulenLudo MahieuVeerle CosseyAlexandra CasaerChristine Van MolKoenraad SmetsElizaveta Padalko

A1 Journal Article in DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

2017

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Isabelle DesombereAhmed Atef Ahmed Abouzeid MesalamRichard A UrbanowiczFreya Van HoutteLieven VerhoyeZhen-Yong KeckAliasghar Farhoudi MoghadamKoen VercauterenKarin WeeningThomas F Baumert et al.

A1 Journal Article in ANTIVIRAL RESEARCH

Characterization of a novel monoclonal antibody targeting epitope II within hepatitis C virus E2 envelope glycoprotein

Philip MeulemanAhmed Atef Ahmed Abouzeid MesalamIsabelle DesombereRichard UrbanowiczFreya Van HoutteLieven VerhoyeZhen-Yong KeckAliasghar Farhoudi MoghadamKoen VercauterenKarin Weening et al.

Development and characterization of a human monoclonal antibody for prevention of HCV recurrence in liver transplant patients

Ahmed Atef Ahmed Abouzeid MesalamIsabelle DesombereRichard UrbanowiczDaniel X JohanssonKoen VercauterenAliasghar Farhoudi MoghadamFreya Van HoutteLieven VerhoyeMats PerssonJonathan Ball et al.

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy

Tanvi KheraDaniel TodtKoen VercauterenC Patrick McClureLieven VerhoyeAliasghar Farhoudi MoghadamSabin BhujuRobert GeffersThomas F BaumertEike Steinmann et al.

A1 Journal Article in ANTIVIRAL RESEARCH

2016

Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies

Catherine FauvelleDaniel J FelmleeEmilie CrouchetJiYoung LeeLaura HeydmannMathieu LefèvreAndrea MagriMarie-Sophie HietIsabel FofanaFrançois Habersetzer et al.

A1 Journal Article in GASTROENTEROLOGY

Characterisation of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line

L Earnest-SilveiraB ChuaR ChinD ChristiansenD JohnsonS HerrmannSA RalphKoen VercauterenAhmed Atef Ahmed Abouzeid MesalamPhilip Meuleman et al.

A1 Journal Article in JOURNAL OF GENERAL VIROLOGY

Characterization of a novel human monoclonal antibody targeting the hepatitis C virus envelope protein

Ahmed Atef Ahmed Abouzeid MesalamIsabelle DesombereRichard UrbanowiczDaniel X JohanssonKoen VercauterenAliasghar Farhoudi MoghadamFreya Van HoutteLieven VerhoyeMats PerssonJonathan Ball et al.

Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1

Paula M PerinSibylle HaidRichard JP BrownJuliane DoerrbeckerKai SchulzeCarsten ZeilingerMarkus von SchaewenBrigitte HellerKoen VercauterenEva Luxenburger et al.

A1 Journal Article in HEPATOLOGY

Mouse systems to model hepatitis C virus treatment and associated resistance

Ahmed Atef Ahmed Abouzeid MesalamKoen VercauterenPhilip Meuleman

A1 Journal Article in VIRUSES-BASEL

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

Koen VercauterenRichard JP BrownAhmed Atef Ahmed Abouzeid MesalamJuliane DoerrbeckerSabin BhujuRobert GeffersNaomi Van den EedeC Patrick McClureFulvia TroiseLieven Verhoye et al.

A1 Journal Article in GUT

2015

A broadly neutralizing monoclonal antibody targeting hepatitis C virus prevents viral infection in vitro and in uPA/SCID mice with humanized liver

Ahmed Atef Ahmed Abouzeid MesalamIsabelle DesombereRichard UrbanowiczDaniel X JohanssonKoen VercauterenAliasghar Farhoudi MoghadamFreya Van HoutteLieven VerhoyeKarin WeeningMats Persson et al.

Animal models for the study of HCV

Koen VercauterenYpe P de JongPhilip Meuleman

A1 Journal Article in CURRENT OPINION IN VIROLOGY

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

Laurent MaillyFei XiaoJoachim LupbergerGarrick K WilsonPhilippe AubertFrançois HT DuongDiego CalabreseCéline LeboeufIsabel FofanaChristine Thumann et al.

A1 Journal Article in NATURE BIOTECHNOLOGY

Is hepatitis E virus an emerging problem in industrialized countries?

Ibrahim Mahmoud Sayed IbrahimAnn-Sofie VercouterSayed F AbdelwahabKoen VercauterenPhilip Meuleman

A1 Journal Article in HEPATOLOGY

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

Koen VercauterenRichard JP BrownAhmed Atef Ahmed Abouzeid MesalamJuliane DoerrbeckerSabin BhujuRobert GeffersNaomi Van den EedeFulvia TroiseLieven VerhoyeThomas Baumert et al.

The emergence of hepatitis E virus in Europe

Ibrahim Mahmoud Sayed IbrahimKoen VercauterenSayed F AbdelwahabPhilip Meuleman

A1 Journal Article in FUTURE VIROLOGY

2014

HCV animal models and liver disease

Koen VercauterenYpe P de JongPhilip Meuleman

A1 Journal Article in JOURNAL OF HEPATOLOGY

Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization

Koen VercauterenAhmed Atef Ahmed Abouzeid MesalamGeert Leroux-RoelsPhilip Meuleman

A1 Journal Article in WORLD JOURNAL OF GASTROENTEROLOGY

Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents

Koen VercauterenNaomi Van den EedeAhmed Atef Ahmed Abouzeid MesalamSandrine BelouzardMaria Teresa CataneseDorothea BankwitzFlossie Wong-StaalRiccardo CorteseJean DubuissonCharles M Rice et al.

A1 Journal Article in HEPATOLOGY

Targeting SR-BI for the prevention and treatment of hepatitis C virus infections

Koen VercauterenPhilip MeulemanGeert Leroux-Roels

2013

The Sin3a repressor complex regulates the balance between the activities of different STAT proteins

Laura IcardiRaffaele MoriViola GesellchenSven EyckermanJudith VerhelstKoen VercauterenXavier SaelensPhilip MeulemanKarolien De BosscherM Boutros et al.

2012

Blocking HCV entry as potential antiviral therapy

Koen VercauterenGeert Leroux-RoelsPhilip Meuleman

A1 Journal Article in FUTURE VIROLOGY

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice

Krzysztof LacekKoen VercauterenKatarzyna GrzybMariarosaria NaddeoLieven VerhoyeMarek Patryk SłowikowskiSamira Fafi-KremerArvind H PatelThomas F BaumertAntonella Folgori et al.

A1 Journal Article in JOURNAL OF HEPATOLOGY

The Sin3a repressor complex is a master regulator of STAT transcriptional activity

Laura IcardiRaffaele MoriViola GesellchenSven EyckermanLode De CauwerJudith VerhelstKoen VercauterenXavier SaelensPhilip MeulemanGeert Leroux-Roels et al.

A1 Journal Article in PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

2011

Griffithsin has antiviral activity against hepatitis C virus

Philip MeulemanAnna AlbeckaSandrine BelouzardKoen VercauterenLieven VerhoyeCzeslaw WychowskiGeert Leroux-RoelsKenneth E PalmerJean Dubuisson

A1 Journal Article in ANTIMICROBIAL AGENTS AND CHEMOTHERAPY